Published in Science on September 12, 2013
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2013) 2.11
Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature (2014) 1.60
Structure of the Angiotensin receptor revealed by serial femtosecond crystallography. Cell (2015) 1.51
Integrated analysis of residue coevolution and protein structures capture key protein sectors in HIV-1 proteins. PLoS One (2015) 1.42
Structural biology. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor. Science (2015) 1.40
Functional Mimetics of the HIV-1 CCR5 Co-Receptor Displayed on the Surface of Magnetic Liposomes. PLoS One (2015) 1.39
Two disparate ligand-binding sites in the human P2Y1 receptor. Nature (2015) 1.25
Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists. Nature (2016) 1.13
A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands. Br J Pharmacol (2014) 1.09
Novel Allosteric Modulators of G Protein-coupled Receptors. J Biol Chem (2015) 1.02
iview: an interactive WebGL visualizer for protein-ligand complex. BMC Bioinformatics (2014) 1.00
Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopy. J Virol (2014) 1.00
From G Protein-coupled Receptor Structure Resolution to Rational Drug Design. J Biol Chem (2015) 0.99
Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides. Sci Transl Med (2014) 0.97
Biased and g protein-independent signaling of chemokine receptors. Front Immunol (2014) 0.96
Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies. Immunol Cell Biol (2015) 0.94
High-resolution mass spectrometry of small molecules bound to membrane proteins. Nat Methods (2016) 0.92
The recombinant expression systems for structure determination of eukaryotic membrane proteins. Protein Cell (2014) 0.89
Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop. PLoS One (2014) 0.88
Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor. J Biol Chem (2014) 0.88
Stoichiometry and geometry of the CXC chemokine receptor 4 complex with CXC ligand 12: molecular modeling and experimental validation. Proc Natl Acad Sci U S A (2014) 0.88
Ligand- and mutation-induced conformational selection in the CCR5 chemokine G protein-coupled receptor. Proc Natl Acad Sci U S A (2014) 0.86
Modelling binding between CCR5 and CXCR4 receptors and their ligands suggests the surface electrostatic potential of the co-receptor to be a key player in the HIV-1 tropism. Retrovirology (2013) 0.85
Molecular Property Design: Does Everyone Get It? ACS Med Chem Lett (2015) 0.85
What can we learn from molecular dynamics simulations for GPCR drug design? Comput Struct Biotechnol J (2014) 0.84
Discovery of GPCR ligands for probing signal transduction pathways. Front Pharmacol (2014) 0.84
Structure-Based Sequence Alignment of the Transmembrane Domains of All Human GPCRs: Phylogenetic, Structural and Functional Implications. PLoS Comput Biol (2016) 0.83
CCR5 blockade for neuroinflammatory diseases - beyond control of HIV. Nat Rev Neurol (2016) 0.83
Structural Studies of G Protein-Coupled Receptors. Mol Cells (2015) 0.82
Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulation. Mol Endocrinol (2015) 0.82
The influence of N-linked glycans on the molecular dynamics of the HIV-1 gp120 V3 loop. PLoS One (2013) 0.82
Role of Marine Natural Products in the Genesis of Antiviral Agents. Chem Rev (2015) 0.82
HIV coreceptor tropism determination and mutational pattern identification. Sci Rep (2016) 0.81
Sequence, structure and ligand binding evolution of rhodopsin-like G protein-coupled receptors: a crystal structure-based phylogenetic analysis. PLoS One (2015) 0.81
Investigation of Inhibition Mechanism of Chemokine Receptor CCR5 by Micro-second Molecular Dynamics Simulations. Sci Rep (2015) 0.81
Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism. BMC Bioinformatics (2015) 0.81
HIV-1 drug resistance and resistance testing. Infect Genet Evol (2016) 0.80
Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices. Proc Natl Acad Sci U S A (2016) 0.80
CCR5 conformations are dynamic and modulated by localization, trafficking and G protein association. PLoS One (2014) 0.80
Large-scale production and protein engineering of G protein-coupled receptors for structural studies. Front Pharmacol (2015) 0.79
Elucidating a key anti-HIV-1 and cancer-associated axis: the structure of CCL5 (Rantes) in complex with CCR5. Sci Rep (2014) 0.79
Gating function of isoleucine-116 in TM-3 (position III:16/3.40) for the activity state of the CC-chemokine receptor 5 (CCR5). Br J Pharmacol (2014) 0.79
Functional assay for T4 lysozyme-engineered G protein-coupled receptors with an ion channel reporter. Structure (2013) 0.79
How Can Mutations Thermostabilize G-Protein-Coupled Receptors? Trends Pharmacol Sci (2015) 0.79
Mechanisms of Regulation of the Chemokine-Receptor Network. Int J Mol Sci (2017) 0.78
An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions. FEBS J (2015) 0.78
Micelle-Enhanced Bioorthogonal Labeling of Genetically Encoded Azido Groups on the Lipid-Embedded Surface of a GPCR. Chembiochem (2015) 0.78
Inhibition of Inflammatory and Neuropathic Pain by Targeting a Mu Opioid Receptor/Chemokine Receptor5 Heteromer (MOR-CCR5). J Med Chem (2015) 0.78
Post-expression strategies for structural investigations of membrane proteins. Curr Opin Struct Biol (2015) 0.78
ASD v3.0: unraveling allosteric regulation with structural mechanisms and biological networks. Nucleic Acids Res (2015) 0.78
Function-specific virtual screening for GPCR ligands using a combined scoring method. Sci Rep (2016) 0.78
A Linear Epitope in the N-Terminal Domain of CCR5 and Its Interaction with Antibody. PLoS One (2015) 0.78
G Protein-Coupled Receptors (GPCRs) in Alzheimer's Disease: A Focus on BACE1 Related GPCRs. Front Aging Neurosci (2016) 0.78
Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines. Front Immunol (2016) 0.77
Multiplex detection of functional G protein-coupled receptors harboring site-specifically modified unnatural amino acids. Biochemistry (2015) 0.77
Opioid receptors: Structural and mechanistic insights into pharmacology and signaling. Eur J Pharmacol (2015) 0.77
The Viral G Protein-Coupled Receptor ORF74 Hijacks β-Arrestins for Endocytic Trafficking in Response to Human Chemokines. PLoS One (2015) 0.77
Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis. Br J Pharmacol (2014) 0.77
Antibody epitopes on g protein-coupled receptors mapped with genetically encoded photoactivatable cross-linkers. Biochemistry (2014) 0.77
Stereochemical assignment of the protein-protein interaction inhibitor JBIR-22 by total synthesis. Angew Chem Int Ed Engl (2015) 0.77
New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model. Biochem Pharmacol (2016) 0.77
A mutagenesis and screening strategy to generate optimally thermostabilized membrane proteins for structural studies. Nat Protoc (2016) 0.77
Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus. PLoS Pathog (2016) 0.77
GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.77
Identification of destabilizing and stabilizing mutations of Ste2p, a G protein-coupled receptor in Saccharomyces cerevisiae. Biochemistry (2015) 0.77
Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation. Sci Signal (2017) 0.76
High yield and efficient expression and purification of the human 5-HT3A receptor. Acta Pharmacol Sin (2015) 0.76
Chemokines and their receptors: insights from molecular modeling and crystallography. Curr Opin Pharmacol (2016) 0.76
Biased Gs Versus Gq Proteins and β-Arrestin Signaling in the NK1 Receptor Determined by Interactions in the Water Hydrogen Bond Network. J Biol Chem (2015) 0.76
Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues. AIDS Res Hum Retroviruses (2016) 0.76
Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue: ROLE OF ILE198. J Biol Chem (2015) 0.76
Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies. Curr Top Med Chem (2014) 0.76
Production of Chemokine/Chemokine Receptor Complexes for Structural Biophysical Studies. Methods Enzymol (2015) 0.76
Peptide ligand recognition by G protein-coupled receptors. Front Pharmacol (2015) 0.76
Hijacking GPCRs by viral pathogens and tumor. Biochem Pharmacol (2016) 0.76
Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural Analysis. PLoS One (2015) 0.76
Structural biology. A new bundle of prospects for blocking HIV-1 entry. Science (2013) 0.76
Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase. ACS Med Chem Lett (2015) 0.76
Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5. Antimicrob Agents Chemother (2014) 0.76
A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity. Retrovirology (2015) 0.76
Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions: EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE. J Biol Chem (2016) 0.76
Structural basis of ligand interaction with atypical chemokine receptor 3. Nat Commun (2017) 0.76
A Large and Phylogenetically Diverse Class of Type 1 Opsins Lacking a Canonical Retinal Binding Site. PLoS One (2016) 0.76
Reduced Baseline Sensitivity to Maraviroc Inhibition Among R5 HIV-1 Isolates From Individuals With Severe Immunodeficiency. J Acquir Immune Defic Syndr (2016) 0.76
On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targets. Br J Pharmacol (2016) 0.76
Molecular dynamics simulations and structure-based network analysis reveal structural and functional aspects of G-protein coupled receptor dimer interactions. J Comput Aided Mol Des (2016) 0.75
Efficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semen. Int J Nanomedicine (2016) 0.75
Short Communication: HIV-1 Variants That Use Mouse CCR5 Reveal Critical Interactions of gp120's V3 Crown with CCR5 Extracellular Loop 1. AIDS Res Hum Retroviruses (2015) 0.75
Lead Screening for HIV of C-C Chemokine Receptor Type 5 Receptor Inhibited by Traditional Chinese Medicine. Evid Based Complement Alternat Med (2014) 0.75
Stereochemical Assignment of the Protein-Protein Interaction Inhibitor JBIR-22 by Total Synthesis. Angew Chem Weinheim Bergstr Ger (2015) 0.75
Structural Analysis of Chemokine Receptor-Ligand Interactions. J Med Chem (2017) 0.75
Preparation and Analysis of N-Terminal Chemokine Receptor Sulfopeptides Using Tyrosylprotein Sulfotransferase Enzymes. Methods Enzymol (2015) 0.75
Highly Accurate Structure-Based Prediction of HIV-1 Coreceptor Usage Suggests Intermolecular Interactions Driving Tropism. PLoS One (2016) 0.75
Identification of the Single Immunodominant Region of the Native Human CC Chemokine Receptor 6 Recognized by Mouse Monoclonal Antibodies. PLoS One (2016) 0.75
Folding of newly translated membrane protein CCR5 is assisted by the chaperonin GroEL-GroES. Sci Rep (2015) 0.75
Evolution of coreceptor utilization to escape CCR5 antagonist therapy. Virology (2016) 0.75
Incompatible Natures of the HIV-1 Envelope in Resistance to the CCR5 Antagonist Cenicriviroc and to Neutralizing Antibodies. Antimicrob Agents Chemother (2015) 0.75
Elucidation of the CCR1- and CCR5-binding modes of MIP-1α by application of an NMR spectra reconstruction method to the transferred cross-saturation experiments. J Biomol NMR (2015) 0.75
Synthetic Peptides as Protein Mimics. Front Bioeng Biotechnol (2016) 0.75
Analysis of Chemokine Receptor Trafficking by Site-Specific Biotinylation. PLoS One (2016) 0.75
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
Features and development of Coot. Acta Crystallogr D Biol Crystallogr (2010) 89.46
Crystal structure of rhodopsin: A G protein-coupled receptor. Science (2000) 28.60
Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature (2011) 13.92
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol (1999) 13.55
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science (2010) 10.30
Chemokines and leukocyte traffic. Nature (1998) 9.79
Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J Mol Biol (1994) 6.41
Crystallizing membrane proteins using lipidic mesophases. Nat Protoc (2009) 6.36
Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science (2010) 5.86
Chemokines and disease. Nat Immunol (2001) 5.62
Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science (2007) 4.35
Structure-function of the G protein-coupled receptor superfamily. Annu Rev Pharmacol Toxicol (2012) 3.83
Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J Virol (1997) 3.44
Structural basis for coreceptor selectivity by the HIV type 1 V3 loop. AIDS Res Hum Retroviruses (2007) 2.19
The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor. Mol Pharmacol (2005) 2.16
Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure (2012) 2.08
Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities. J Biol Chem (2000) 2.07
Assessing chemokine co-receptor usage in HIV. Curr Opin Infect Dis (2005) 1.84
CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood (1999) 1.75
The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. J Biol Chem (2002) 1.46
Pharmacological modulation of chemokine receptor function. Br J Pharmacol (2012) 1.41
Recognition of RANTES by extracellular parts of the CCR5 receptor. J Mol Biol (2006) 1.35
Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding. J Virol (2002) 1.33
Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5). J Biol Chem (2011) 1.25
New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection. J Biol Chem (2010) 1.16
The relative activity of "function sparing" HIV-1 entry inhibitors on viral entry and CCR5 internalization: is allosteric functional selectivity a valuable therapeutic property? Mol Pharmacol (2008) 1.01
Functional impact of HIV coreceptor-binding site mutations. Virology (2006) 1.00
FDA notifications. Maraviroc approved as a CCR5 co-receptor antagonist. AIDS Alert (2007) 0.97
Discovery and development of small-molecule chemokine coreceptor CCR5 antagonists. J Med Chem (2006) 0.96
Discovery of a piperidine-4-carboxamide CCR5 antagonist (TAK-220) with highly potent Anti-HIV-1 activity. J Med Chem (2006) 0.91
Characterization of a dual-tropic human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2. Virology (2013) 0.86
Genome sequencing in microfabricated high-density picolitre reactors. Nature (2005) 150.21
A draft sequence of the rice genome (Oryza sativa L. ssp. indica). Science (2002) 42.78
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science (2007) 20.32
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science (2007) 11.74
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science (2008) 11.74
Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet (2012) 10.53
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science (2010) 10.30
The marine viromes of four oceanic regions. PLoS Biol (2006) 10.19
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol (2009) 9.67
Genome-wide association studies of 14 agronomic traits in rice landraces. Nat Genet (2010) 8.75
Genomewide association study of leprosy. N Engl J Med (2009) 8.17
Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell (2011) 7.30
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature (2005) 7.24
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet (2009) 6.42
Crystallizing membrane proteins using lipidic mesophases. Nat Protoc (2009) 6.36
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
Structure of an agonist-bound human A2A adenosine receptor. Science (2011) 6.21
A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure (2008) 6.01
Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline. Proc Natl Acad Sci U S A (2002) 6.00
Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science (2010) 5.86
Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell (2010) 5.77
High-throughput genotyping by whole-genome resequencing. Genome Res (2009) 5.74
Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science (2007) 5.49
Structure of the human κ-opioid receptor in complex with JDTic. Nature (2012) 5.18
Global diversity in the human salivary microbiome. Genome Res (2009) 5.16
Metabolite identification via the Madison Metabolomics Consortium Database. Nat Biotechnol (2008) 5.12
A map of rice genome variation reveals the origin of cultivated rice. Nature (2012) 4.92
Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res (2002) 4.92
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res (2011) 4.55
Sequence and analysis of rice chromosome 4. Nature (2002) 4.39
The Rice Annotation Project Database (RAP-DB): 2008 update. Nucleic Acids Res (2007) 4.23
Metagenomic analysis of the microbial community associated with the coral Porites astreoides. Environ Microbiol (2007) 4.21
Genome-wide association study of flowering time and grain yield traits in a worldwide collection of rice germplasm. Nat Genet (2011) 4.19
IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest (2008) 4.12
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol (2011) 4.09
A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome. Genome Res (2008) 4.06
Modification of kidney barrier function by the urokinase receptor. Nat Med (2007) 4.01
Pluripotent stem cells from the adult mouse inner ear. Nat Med (2003) 3.92
Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation (2013) 3.91
Structure-function of the G protein-coupled receptor superfamily. Annu Rev Pharmacol Toxicol (2012) 3.83
Identification of ligands for DAF-12 that govern dauer formation and reproduction in C. elegans. Cell (2006) 3.82
Neural correlates of behavioral preference for culturally familiar drinks. Neuron (2004) 3.80
Crystal structure of a lipid G protein-coupled receptor. Science (2012) 3.78
Exchange-coupled nanocomposite magnets by nanoparticle self-assembly. Nature (2002) 3.71
Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol (2003) 3.69
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature (2010) 3.59
Serial femtosecond crystallography of G protein-coupled receptors. Science (2013) 3.58
The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature (2007) 3.55
Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens. Clin Infect Dis (2013) 3.49
Structure of the human histamine H1 receptor complex with doxepin. Nature (2011) 3.48
Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology (2006) 3.46
Analyses and comparison of accuracy of different genotype imputation methods. PLoS One (2008) 3.41
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med (2016) 3.40
Structural basis for allosteric regulation of GPCRs by sodium ions. Science (2012) 3.40
Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc Natl Acad Sci U S A (2007) 3.37
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med (2011) 3.19
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother (2007) 3.15
Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet (2010) 3.15
Curated genome annotation of Oryza sativa ssp. japonica and comparative genome analysis with Arabidopsis thaliana. Genome Res (2007) 3.13
NELF and GAGA factor are linked to promoter-proximal pausing at many genes in Drosophila. Mol Cell Biol (2008) 3.11
Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol (2005) 3.11
Structure of the human smoothened receptor bound to an antitumour agent. Nature (2013) 3.08
Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR. Science (2012) 3.07
Predicting protein-protein interactions based only on sequences information. Proc Natl Acad Sci U S A (2007) 3.06
Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase. Clin Infect Dis (2011) 3.06
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother (2010) 3.03
Preoperative aspirin use and outcomes in cardiac surgery patients. Ann Surg (2012) 3.03
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature (2012) 2.96
Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (2006) 2.95
Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation (2010) 2.95
Viral and microbial community dynamics in four aquatic environments. ISME J (2010) 2.95
Microscale fluorescent thermal stability assay for membrane proteins. Structure (2008) 2.95
Stimulation-dependent recycling of integrin beta1 regulated by ARF6 and Rab11. Traffic (2004) 2.91
Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol Sci (2011) 2.89
Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme. J Infect (2008) 2.88
Structure of the human glucagon class B G-protein-coupled receptor. Nature (2013) 2.86